Ovarian cancer with peritoneal metastases has many treatment options and HIPEC is here to stay
- PMID: 33970163
- PMCID: PMC8100724
- DOI: 10.21037/jgo-2020-17
Ovarian cancer with peritoneal metastases has many treatment options and HIPEC is here to stay
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jgo-2020-17). The focused issue was sponsored by the Peritoneal Surface Oncology Group International (PSOGI). Drs. PHS and KVDS served as the unpaid Guest Editors of the focused issue. The authors have no other conflicts of interest to declare.
Comment on
-
Narrative review of cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases in ovarian cancer.J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S137-S143. doi: 10.21037/jgo-20-274. J Gastrointest Oncol. 2021. PMID: 33968434 Free PMC article. Review.
-
Intraperitoneal chemotherapy for ovarian cancer with peritoneal metastases, systematic review of the literature and focused personal experience.J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S144-S181. doi: 10.21037/jgo-2020-06. J Gastrointest Oncol. 2021. PMID: 33968435 Free PMC article. Review.
-
Narrative review of hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian cancer: a critical reappraisal of the current evidence.J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S182-S188. doi: 10.21037/jgo-20-130. J Gastrointest Oncol. 2021. PMID: 33968436 Free PMC article. Review.
Similar articles
-
Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Eur J Surg Oncol. 2014 Aug;40(8):937-42. doi: 10.1016/j.ejso.2014.02.238. Epub 2014 Feb 28. Eur J Surg Oncol. 2014. PMID: 24630923
-
Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review.JAMA Oncol. 2021 Aug 1;7(8):1231-1238. doi: 10.1001/jamaoncol.2021.0580. JAMA Oncol. 2021. PMID: 33956063 Review.
-
Diagnostic Nodes of Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Among Colorectal Cancer Patients: A Swiss National Multicenter Survey.Clin Colorectal Cancer. 2019 Dec;18(4):e335-e342. doi: 10.1016/j.clcc.2019.06.002. Epub 2019 Jun 26. Clin Colorectal Cancer. 2019. PMID: 31371166
-
Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases.Eur J Cancer. 2014 Jan;50(2):332-40. doi: 10.1016/j.ejca.2013.09.024. Epub 2013 Oct 21. Eur J Cancer. 2014. PMID: 24157254 Review.
-
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial.Lancet Gastroenterol Hepatol. 2019 Oct;4(10):761-770. doi: 10.1016/S2468-1253(19)30239-0. Epub 2019 Jul 29. Lancet Gastroenterol Hepatol. 2019. PMID: 31371228 Clinical Trial.
Cited by
-
The Role of Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in Recurrent Ovarian Peritoneal Carcinomatosis.J Pers Med. 2024 Jul 11;14(7):742. doi: 10.3390/jpm14070742. J Pers Med. 2024. PMID: 39063996 Free PMC article.
-
Comparative Sensing and Judgment Control System for Temperature Maintenance for Optimal Treatment in Hyperthermic Intraperitoneal Chemotherapy Surgery.Sensors (Basel). 2024 Jan 17;24(2):596. doi: 10.3390/s24020596. Sensors (Basel). 2024. PMID: 38257692 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources